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The most recent European Society of Cardiology (ESC)
guidelines recommend primary percutaneous coronary inter-
vention (PCI) as the preferred treatment for ST-segment ele-
vation myocardial infarction (STEMI) whenever it is available
within 90–120 min of the first medical contact [1]. However,
timing of symptom onset appears to be hard to adjudicate
precisely, and ‘ischaemic time’ thereby usually exceeds 3 h,
the exact threshold after which infarct size starts to increase
and long-term survival significantly starts to decline [2].
Fragmenting the different intervals of ischaemic time in the
present study is therefore interesting when assessing how and
where there is still room for improvement. Let us analyse the
intervals in a time-dependent fashion.
First, symptom onset to diagnosis. As mentioned, precise
determination of symptom onset is challenging and Postma
et al. demonstrate that the interquartile range suggests times
varying between 30 min and 4 to 5 h, reflecting daily clinical
practice in which patients do not always directly recognise
alarm symptoms and call for medical contact [3]. What is
more interesting, however, is the significant difference be-
tween time of symptom onset and diagnosis, which is roughly
30 min shorter in patients picked up by ambulances with field
triage capabilities versus those referred first to hospitals with-
out primary PCI facilities (spoke hospitals). Again it is pre-
cisely this 30-minute delay that proved to result in an 8 %
relative increase in 1-year mortality in STEMI patients [4].
Second, diagnosis-to-door PCI, the item in which distance
to, reachability and density of PCI facilities comes into play.
In Europe, first medical contact-to-balloon time ranges be-
tween 60 and 177 min, irrespective of whether the patient
underwent interhospital transfer or not (approximately 50% in
Europe). In the Netherlands there is at present, with 30 facil-
ities, a relatively close density of primary PCI centres (roughly
1/560,000 inhabitants). In European countries offering prima-
ry PCI to the majority of their STEMI patients, this population
varies between 0.3 and 1.1 million per centre [5]. The density
of centres offering specific and in this case complex and high-
risk procedures has been the topic of debate in both the
medical literature and lay press. In general, a high-volume
load for operators and institutions is associated with better
outcomes [6]. More specifically for primary PCI, while pa-
tients treated in high-volume centres still tend to have shorter
door-to-balloon times, there is conflicting evidence on the
existence of better survival rates in patients treated in high-
versus lower-volume centres [7]. To assess if there is an
adequate balance between volume load (and possibly out-
come) and geographical spread and density of Dutch PCI
sites, dedicated registries are needed to compare national
outcomes with other Western countries.
Third, door-to-balloon times. Door-to-balloon times
<90 min were shown to significantly decrease the incidence
of major adverse cardiac events [8]. While local and nation-
wide programs proved to further optimise door-to-balloon
times, recent literature has questioned whether further reduc-
tions will result in an additional decrease in mortality [9].
In the present study, Postma et al. assess the impact of
residential distance on time to treatment in STEMI patients.
The authors used a cohort of 4149 STEMI patients referred to
their hospital between 2004 and 2010 and assessed whether
there was a significant difference in ischaemic time in patients
referred through a spoke centre or following direct triage in
the ambulance, taking into account residential difference. The
authors conclude that a longer distance from the patient’s
residence to the PCI centre was associated with a significant
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increase in time to treatment, a somewhat expected finding
that illustrates the importance of adequate field triage by
ambulance personnel avoiding potential unnecessary referral
to a spoke centre [10]. What was remarkable, however, was
that in the ambulance patients, a longer residential distance to
the PCI site did not lead to a longer ischaemic time although
the diagnosis-to-door PCI times appeared to be 41 min in
patients living within 30 km of the PCI to over 1 h in patients
living 60–90 km away. Since cathlab staff are usually called in
at the moment the diagnosis has been confirmed and are
supposed to be up and runningwithin 30min, this discrepancy
is hard to explain, especially since the door-to-balloon time
should be added to this period increasing the average
diagnosis-to-balloon time to over 90 min.
Second, the time interval between symptom onset and
diagnosis in the spoke group appeared to increase with longer
residential distance ‘to the PCI site’. With the density of
hospitals in the Netherlands, there should almost always be
one within 30 km of the patient’s residence making the delays
in symptom onset to diagnosis depending on patients’ resi-
dence hard to explain.
Third, the authors hypothesised that the effect of distance
on outcome might be different for spoke patients versus
ambulance patients. Unfortunately, the results of the study
preclude any conclusions on this question since no outcomes
were reported.
A final and perhaps most questionable finding of the pres-
ent study was that even after 2004, when field triage by
ambulance services should have been readily available, over
one-third of the STEMI population was referred to a spoke
centre without primary PCI facilities. Unfortunately the data
presented preclude any statements on whether this was due to
lack of field triage equipment in the ambulance, which is
unlikely after 2004, insufficient training of the ambulance staff
or potential other confounders such as the unavailability of
ECG interpreting software precluding an immediate diagnosis
[10]. That adequate field triage significantly decreases ischae-
mic time and improves outcome does not need any further
clarification. The fact that 34 % of the patients, however, were
not, or not adequately triaged by ambulance services is wor-
rying and further scrutinising of these figures might open the
door to further improvement in STEMI care. Previously,
Mahmoud et al. demonstrated that interhospital transfer led
to a twofold increase in 1-year mortality in STEMI patients
[10]. Along the same lines they found clear differences in
patient characteristics between the two groups complicating
the diagnosis in the spoke group (e.g. higher age, female sex
and diabetes), a finding that was not observed by Postma et al.
Nevertheless, commenting on the specific results of the
present study is in the end merely a detail and only relative
to the scope of the problem. The authors should be applauded
for providing a detailed analysis on the specific subsections of
ischaemic time in their primary PCI population. Analyses like
this should be an example on how logistics and quality of care
in a highly developed country as the Netherlands could be
monitored and reported. Especially, since it concerns a coun-
try in which the primary PCI facility density is high, rules and
regulations are becoming stricter and the need for nationwide
quality control registries mandated by national health care
institutions is increasing. It is therefore striking to see that in
a recent overview document of the ESC, in which the current
STEMI care in Europe is assessed among 30 countries, na-
tional data for incidences of STEMI, in-hospital mortality,
median time delays to reperfusion therapy and referral strate-
gies are largely lacking for the Netherlands [5, 11].
At present, we are close, but not close enough to fulfilling
the duty to report high-quality nationwide data on STEMI
care. However, with several working groups and agencies
such as ‘Meetbaar beter’, ‘NVVC Connect’, and the National
Cardiovascular Data Registry currently joining forces to tack-
le this hurdle, there is light at the horizon.
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